ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1252

Rheuminating About Drugs, Sex, and Alcohol? Assessing the Informational Needs of Adolescents and Young Adults with Rheumatic Disease

Matthew Sholdice1, Meghan Pancucci2, gauri gupta3, Simran Heera4, KAREN BEATTIE5 and Michelle Batthish6, 1McMaster University, London, ON, Canada, 2McMaster University, Hamilton, Canada, 3McMaster Univeresity, Hamilton, Canada, 4McMaster University, Mississauga, ON, Canada, 5McMaster University, Hamilton, ON, Canada, 6McMaster Children's Hospital, Hamilton, ON, Canada

Meeting: ACR Convergence 2024

Keywords: Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Patient Outcomes, Preferences, & Attitudes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Adolescents and young adults (AYA) with chronic rheumatic disease (RD) often engage in behaviours, such as alcohol consumption, recreational drug use, and sexual activity, that, when combined with their medications and RD, may impact their disease and overall well-being. However, educational resources focused on how these behaviours may affect their disease and interact with their medications are limited. Our study aimed to understand the informational needs of AYA with RD regarding alcohol, recreational drugs and sexual health, and their impact on their disease and medication.

Methods: An online survey co-developed with patient partners was circulated to AYA, 16-22 years old with RD, in rheumatology clinics and through patient-focused social media networks, from August 2023 to June 2024. The survey was split into 3 sections and asked i) how informed AYA felt regarding specific topics about alcohol and drug consumption, and sexual health, ii) how comfortable they felt discussing these topics with their healthcare provider and parents, and iii) how they preferred to receive the information. Responses using a 5-point Likert scale (e.g. very well informed to not informed at all) were summarized using descriptive statistics.

Results: Of 68 respondents, 84% were female, 57% were 16-18 years old, and 63% had  JIA. Regarding alcohol and drug use, participants felt poorly informed on how to manage symptoms after drug (73%) and alcohol (59%) consumption (Figure 1), how different types of recreational drugs (69%) and alcohol (57%) interact with medications, the safe time to consume drugs (69%), the safe frequency of drug consumption (66%), and the safe amount of drug consumption (59%). The majority felt well informed regarding the short- and long-term impacts of drugs (58%, 61%) and alcohol (75%, 75%), drug addictions (76%), the safe amount of alcohol consumption (69%), and binge drinking (66%). Concerning sexual health, many AYA felt well informed on sexually transmitted infections (79%), pregnancy (68%), and barrier contraception (60%). Fewer respondents felt informed on considerations when becoming a parent (53%).

Of 22 topics raised in the survey about drug and alcohol use and sexual health, the majority of AYA wanted more information on 20 (91%) of them. When asked how they would like to receive the information, the top-rated resources were websites, their healthcare team, and educational pamphlets (Figure 2).  Most AYA reported feeling comfortable talking to their family and doctor about drug (61%, 69%) and alcohol (85%, 84%) use. However, 54% reported being uncomfortable integrating family and caregivers into conversations about sexual health in the clinic.

Conclusion: Our survey results revealed AYA feel poorly informed about some potentially harmful activities related to their RD and medication. Even in areas where they felt informed, AYA expressed desire for more information. Our next steps include conducting focus groups, to further explore AYA’s preferences for how (e.g., website, videos, pamphlet, etc.), when (e.g., starting age), and how often (e.g., every visit, annually) AYA would like to receive this information.

Supporting image 1

Figure 1: Responses to “How well informed are you about managing your symptoms after ___ use”.

Supporting image 2

Figure 2: Responses to “Please select all the ways you would like to receive the information”. Maximum of 3 selections were allowed for alcohol consumption, drug use, and sexual health. Votes from all 3 topics were added together.


Disclosures: M. Sholdice: None; M. Pancucci: None; g. gupta: None; S. Heera: None; K. BEATTIE: None; M. Batthish: Abbvie, 6, Novartis, 2, Viatris, 12, Unrestricted Educational Grant.

To cite this abstract in AMA style:

Sholdice M, Pancucci M, gupta g, Heera S, BEATTIE K, Batthish M. Rheuminating About Drugs, Sex, and Alcohol? Assessing the Informational Needs of Adolescents and Young Adults with Rheumatic Disease [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/rheuminating-about-drugs-sex-and-alcohol-assessing-the-informational-needs-of-adolescents-and-young-adults-with-rheumatic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheuminating-about-drugs-sex-and-alcohol-assessing-the-informational-needs-of-adolescents-and-young-adults-with-rheumatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology